IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical (ICCM) has 3 years of Long-Term Deferred Tax data on file, last reported at $17.2 million in Q4 2022.

• On a quarterly basis, Long-Term Deferred Tax rose 20.95% year-over-year to $17.2 million in Q4 2022; TTM through Dec 2022 was $17.2 million, a 20.95% increase from a year earlier, with the FY2022 full-year figure at $17.2 million, up 20.95% from the prior year.
• Long-Term Deferred Tax for Q4 2022 stood at $17.2 million, up from $14.2 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for ICCM reached as high as $17.2 million in Q4 2022 and fell as low as $12.0 million in Q4 2020.
• Historically, Long-Term Deferred Tax has averaged $14.5 million across 3 years, with a median of $14.2 million in 2021.
• Across the five-year window, Long-Term Deferred Tax climbed 18.44% in 2021 and gained 20.95% in 2022, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $12.0 million in 2020, then rose by 18.44% to $14.2 million in 2021, then gained by 20.95% to $17.2 million in 2022.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $17.2 million in Q4 2022, $14.2 million in Q4 2021, and $12.0 million in Q4 2020.